Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer

G. Porzio, C. Ficorella, G. Toro, I. Paris, E. Ricevuto, P. Marchetti

Research output: Contribution to journalArticle

Abstract

Twenty patients with locally advanced cervical cancer (FIGO stage Ib-IIa "bulky"/IIb) were treated with three courses of weekly PVB (day 1: cisplatin, 50 mg/m2; vincristin, 1 mg/m2; bleomycin, 30 IU over 24-hr) in a neoadjuvant setting. Toxicity was generally mild (no grade 3-4 toxicity was observed), and the treatment was well tolerated without reduction of programmed dose intensity. Fourteen patients (70%) experienced a clinical response and underwent surgery within 20 days after the third course of chemotherapy. Six patients (30%) with stable disease were treated with salvage radiotherapy. Two of the 14 responders experienced a pathologic complete response (14.2%); microscopic disease was detected in one patient with clinical complete response. Pelvic node metastases were found in 4/14 patients (28.5%) and microscopic parametrium involvement in 3/14 (21.4%). All 14 patients had free margins of resection. A short-term weekly platinum-based chemotherapy is highly effective, has little toxicity, and allows a prompt salvage therapy for nonresponding patients.

Original languageEnglish
Pages (from-to)25-26
Number of pages2
JournalTumori
Volume87
Issue number1
Publication statusPublished - 2001

Fingerprint

Uterine Cervical Neoplasms
Drug Therapy
Therapeutics
Salvage Therapy
Peritoneum
Bleomycin
Platinum
Cisplatin
Radiotherapy
Neoplasm Metastasis

Keywords

  • Cervical cancer
  • Neoadjuvant chemotherapy
  • Weekly schedule

ASJC Scopus subject areas

  • Cancer Research

Cite this

Porzio, G., Ficorella, C., Toro, G., Paris, I., Ricevuto, E., & Marchetti, P. (2001). Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tumori, 87(1), 25-26.

Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. / Porzio, G.; Ficorella, C.; Toro, G.; Paris, I.; Ricevuto, E.; Marchetti, P.

In: Tumori, Vol. 87, No. 1, 2001, p. 25-26.

Research output: Contribution to journalArticle

Porzio, G, Ficorella, C, Toro, G, Paris, I, Ricevuto, E & Marchetti, P 2001, 'Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer', Tumori, vol. 87, no. 1, pp. 25-26.
Porzio G, Ficorella C, Toro G, Paris I, Ricevuto E, Marchetti P. Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tumori. 2001;87(1):25-26.
Porzio, G. ; Ficorella, C. ; Toro, G. ; Paris, I. ; Ricevuto, E. ; Marchetti, P. / Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. In: Tumori. 2001 ; Vol. 87, No. 1. pp. 25-26.
@article{a8f88715be5f4f6aa7ebfcf3657698f8,
title = "Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer",
abstract = "Twenty patients with locally advanced cervical cancer (FIGO stage Ib-IIa {"}bulky{"}/IIb) were treated with three courses of weekly PVB (day 1: cisplatin, 50 mg/m2; vincristin, 1 mg/m2; bleomycin, 30 IU over 24-hr) in a neoadjuvant setting. Toxicity was generally mild (no grade 3-4 toxicity was observed), and the treatment was well tolerated without reduction of programmed dose intensity. Fourteen patients (70{\%}) experienced a clinical response and underwent surgery within 20 days after the third course of chemotherapy. Six patients (30{\%}) with stable disease were treated with salvage radiotherapy. Two of the 14 responders experienced a pathologic complete response (14.2{\%}); microscopic disease was detected in one patient with clinical complete response. Pelvic node metastases were found in 4/14 patients (28.5{\%}) and microscopic parametrium involvement in 3/14 (21.4{\%}). All 14 patients had free margins of resection. A short-term weekly platinum-based chemotherapy is highly effective, has little toxicity, and allows a prompt salvage therapy for nonresponding patients.",
keywords = "Cervical cancer, Neoadjuvant chemotherapy, Weekly schedule",
author = "G. Porzio and C. Ficorella and G. Toro and I. Paris and E. Ricevuto and P. Marchetti",
year = "2001",
language = "English",
volume = "87",
pages = "25--26",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer

AU - Porzio, G.

AU - Ficorella, C.

AU - Toro, G.

AU - Paris, I.

AU - Ricevuto, E.

AU - Marchetti, P.

PY - 2001

Y1 - 2001

N2 - Twenty patients with locally advanced cervical cancer (FIGO stage Ib-IIa "bulky"/IIb) were treated with three courses of weekly PVB (day 1: cisplatin, 50 mg/m2; vincristin, 1 mg/m2; bleomycin, 30 IU over 24-hr) in a neoadjuvant setting. Toxicity was generally mild (no grade 3-4 toxicity was observed), and the treatment was well tolerated without reduction of programmed dose intensity. Fourteen patients (70%) experienced a clinical response and underwent surgery within 20 days after the third course of chemotherapy. Six patients (30%) with stable disease were treated with salvage radiotherapy. Two of the 14 responders experienced a pathologic complete response (14.2%); microscopic disease was detected in one patient with clinical complete response. Pelvic node metastases were found in 4/14 patients (28.5%) and microscopic parametrium involvement in 3/14 (21.4%). All 14 patients had free margins of resection. A short-term weekly platinum-based chemotherapy is highly effective, has little toxicity, and allows a prompt salvage therapy for nonresponding patients.

AB - Twenty patients with locally advanced cervical cancer (FIGO stage Ib-IIa "bulky"/IIb) were treated with three courses of weekly PVB (day 1: cisplatin, 50 mg/m2; vincristin, 1 mg/m2; bleomycin, 30 IU over 24-hr) in a neoadjuvant setting. Toxicity was generally mild (no grade 3-4 toxicity was observed), and the treatment was well tolerated without reduction of programmed dose intensity. Fourteen patients (70%) experienced a clinical response and underwent surgery within 20 days after the third course of chemotherapy. Six patients (30%) with stable disease were treated with salvage radiotherapy. Two of the 14 responders experienced a pathologic complete response (14.2%); microscopic disease was detected in one patient with clinical complete response. Pelvic node metastases were found in 4/14 patients (28.5%) and microscopic parametrium involvement in 3/14 (21.4%). All 14 patients had free margins of resection. A short-term weekly platinum-based chemotherapy is highly effective, has little toxicity, and allows a prompt salvage therapy for nonresponding patients.

KW - Cervical cancer

KW - Neoadjuvant chemotherapy

KW - Weekly schedule

UR - http://www.scopus.com/inward/record.url?scp=0035064789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035064789&partnerID=8YFLogxK

M3 - Article

C2 - 11669553

AN - SCOPUS:0035064789

VL - 87

SP - 25

EP - 26

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 1

ER -